EMILY JO BOBE FNP-C
Prescription History 1083170161
Nurse Practitioner in Vincennes, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for EMILY JO BOBE FNP-C, an active Nurse Practitioner specialist practicing in Vincennes, IN. Our medical registry currently tracks 13 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 527 documented patient claims. Among these therapy options, the most frequently utilized medication is Fluorouracil, which accounts for 123 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| Fluorouracil | 123 | $67.55▼ below IN avg | ▲ More than typical |
About Fluorouracil: This medication is used on the skin to treat pre-cancerous and cancerous skin growths. Show more ▾ Fluorouracil belongs to a class of medications known as anti-metabolites. It works by blocking the growth of abnormal cells that cause the skin condition. A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. In 2024, this provider wrote 123 Medicare prescriptions for Fluorouracil, about 2.5 times the volume of the typical Indiana prescriber of this medication (49.7). Medicare paid an average of $67.55 per fill, versus $76.39 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 131 30-Day Fills standardized to 30-day supplies 3,678 Days of Medication total across all patients in 2024 | |||
| Ketoconazole | 111 | $11.01▼ below IN avg | ▲ More than typical |
About Ketoconazole: Ketoconazole is used to treat skin infections such as athlete's foot, jock itch, ringworm, and certain kinds of dandruff. Show more ▾ This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Ketoconazole is an azole antifungal that works by preventing the growth of fungus. Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. In 2024, this provider wrote 111 Medicare prescriptions for Ketoconazole, about 2.1 times the volume of the typical Indiana prescriber of this medication (53.8). Medicare paid an average of $11.01 per fill, versus $16.59 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 116 30-Day Fills standardized to 30-day supplies 3,258 Days of Medication total across all patients in 2024 | |||
| Triamcinolone Acetonide | 70 | $5.45▼ below IN avg | ▲ More than typical |
About Triamcinolone Acetonide: This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, allergies, rash). Show more ▾ Triamcinolone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium- to strong-potency corticosteroid. The potency depends on the strength and the form that you use. For details on the potency of your product, ask your pharmacist. An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions. In 2024, this provider wrote 70 Medicare prescriptions for Triamcinolone Acetonide, about 2 times the volume of the typical Indiana prescriber of this medication (35.6). Medicare paid an average of $5.45 per fill, versus $9.14 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 71 30-Day Fills standardized to 30-day supplies 1,733 Days of Medication total across all patients in 2024 | |||
| Clobetasol Propionate | 61 | $52.87 | ▲ More than typical |
About Clobetasol Propionate: This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Show more ▾ Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid. A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression. In 2024, this provider wrote 61 Medicare prescriptions for Clobetasol Propionate, about 1.5 times the volume of the typical Indiana prescriber of this medication (41.5). Medicare paid an average of $52.87 per fill, versus $41.17 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 61 30-Day Fills standardized to 30-day supplies 1,732 Days of Medication total across all patients in 2024 | |||
| Nystatin | 25 | $12.98▼ below IN avg | ≈ Typical |
About Nystatin: Nystatin is used to treat fungal skin infections. Show more ▾ Nystatin is an antifungal that works by stopping the growth of fungus. Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. In 2024, this provider wrote 25 Medicare prescriptions for Nystatin, about the same volume as the typical Indiana prescriber of this medication (25.9). Medicare paid an average of $12.98 per fill, versus $20.44 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 25 30-Day Fills standardized to 30-day supplies 650 Days of Medication total across all patients in 2024 | |||
| Imiquimod | 24 | $41.31 | ≈ Typical |
About Imiquimod: This medication is used to treat certain types of growths on the skin. Show more ▾ These are precancerous growths (actinic keratoses), a certain type of skin cancer (superficial basal cell carcinoma), and warts on the outside of the genitals/anus. Treating these conditions can decrease complications from them. Imiquimod belongs to a group of drugs called immune response modifiers. It is believed to work by helping to activate your immune system to fight these abnormal skin growths. This product is not recommended for use on children under 12 years of age unless specifically directed by your doctor. A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial BASAL CELL CARCINOMA; and ACTINIC KERATOSIS. In 2024, this provider wrote 24 Medicare prescriptions for Imiquimod, about 82% of the volume of the typical Indiana prescriber of this medication (29.3). Medicare paid an average of $41.31 per fill, versus $27.82 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27.8 30-Day Fills standardized to 30-day supplies 824 Days of Medication total across all patients in 2024 | |||
| Metronidazole | 21 | $47.48 | ≈ Typical |
About Metronidazole: Metronidazole is an antibiotic that is used to treat a wide variety of infections. Show more ▾ It works by stopping the growth of certain bacteria and parasites. This antibiotic treats only certain bacterial and parasitic infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Metronidazole may also be used with other medications to treat certain stomach/intestinal ulcers caused by a bacteria (H. pylori). A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. In 2024, this provider wrote 21 Medicare prescriptions for Metronidazole, about the same volume as the typical Indiana prescriber of this medication (22.1). Medicare paid an average of $47.48 per fill, versus $32.49 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 578 Days of Medication total across all patients in 2024 | |||
| Clindamycin Phosphate | 19 | $25.80▼ below IN avg | ▼ Less than typical |
About Clindamycin Phosphate: This medication is used to treat acne. Show more ▾ It helps to decrease the number of acne lesions. Clindamycin is an antibiotic which works by stopping the growth of bacteria. An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. In 2024, this provider wrote 19 Medicare prescriptions for Clindamycin Phosphate, about 65% of the volume of the typical Indiana prescriber of this medication (29.4). Medicare paid an average of $25.80 per fill, versus $37.32 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 19 30-Day Fills standardized to 30-day supplies 455 Days of Medication total across all patients in 2024 | |||
| OtezlaApremilast | 17 | $4,581.27▼ below IN avg | ▼ Less than typical |
About Otezla: This medication is used to treat a certain type of arthritis (psoriatic arthritis). Show more ▾ Apremilast is also used to treat a certain type of skin condition (moderate to severe plaque psoriasis). Apremilast belongs to a class of drugs known as phosphodiesterase 4 (PDE4) inhibitors. For the treatment of psoriatic arthritis, it decreases pain and swelling, and may help improve flexibility in the affected joints. For the treatment of plaque psoriasis, it may help to reduce the redness, thickening, and scaling of the skin that occurs with this condition. Apremilast is also used to treat mouth sores in people who have Behcet's disease. It helps to reduce the pain and improve the healing of these mouth sores. A PDE4 inhibitor with anti-ulcer activity. In 2024, this provider wrote 17 Medicare prescriptions for Otezla, about 70% of the volume of the typical Indiana prescriber of this medication (24.3). Medicare paid an average of $4,581.27 per fill, versus $4,777.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2024 | |||
| Calcipotriene | 16 | $164.30 | ≈ Typical |
About Calcipotriene: This medication is used to treat psoriasis. Show more ▾ Calcipotriene is a form of vitamin D. It works by slowing down the growth of skin cells. A topical dermatologic for the treatment of moderate plaque psoriasis. In 2024, this provider wrote 16 Medicare prescriptions for Calcipotriene, about 89% of the volume of the typical Indiana prescriber of this medication (17.9). Medicare paid an average of $164.30 per fill, versus $145.50 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 515 Days of Medication total across all patients in 2024 | |||
| Cosentyx Sensoready (2 Pens)Secukinumab | 14 | $7,256.06▼ below IN avg | ▼ Less than typical |
About Cosentyx Sensoready (2 Pens): This medication is used to treat plaque psoriasis and certain types of arthritis (such as arthritis of the spine, psoriatic arthritis, axial spondyloarthritis, enthesitis-related arthritis). Show more ▾ It is also used to treat a certain skin disorder (hidradenitis suppurativa). Secukinumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-17A) that may cause inflammation and swelling. A fully human antibody to interleukin-17A for treatment of psoriasis, rheumatoid arthritis, and uveitis. In 2024, this provider wrote 14 Medicare prescriptions for Cosentyx Sensoready (2 Pens), about 62% of the volume of the typical Indiana prescriber of this medication (22.6). Medicare paid an average of $7,256.06 per fill, versus $7,970.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2024 | |||
| MethotrexateMethotrexate Sodium | 14 | $24.53 | ▼ Less than typical |
About Methotrexate: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma), severe psoriasis that has not responded to other treatments, or rheumatoid arthritis. Show more ▾ It may also be used to treat a certain type of arthritis in children (polyarticular juvenile idiopathic arthritis - pJIA). Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and blocking the immune system from attacking healthy tissue. Early treatment of rheumatoid arthritis with methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. In 2024, this provider wrote 14 Medicare prescriptions for Methotrexate, about 14% of the volume of the typical Indiana prescriber of this medication (103.2). Medicare paid an average of $24.53 per fill, versus $22.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37.7 30-Day Fills standardized to 30-day supplies 1,128 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 12 | $18.02 | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 12 Medicare prescriptions for Doxycycline Hyclate, about a third of the volume of the typical Indiana prescriber of this medication (32.4). Medicare paid an average of $18.02 per fill, versus $12.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 237 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for EMILY JO BOBE FNP-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Vincennes, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among IN prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
